References
- Matzkin H, Regev S. Naturally acquired immunity to tetanus in an isolated community. Infect. Immun.48, 267–268 (1985).
- Furste W. Tetanus statistics. JAMA228, 28 (1974).
- Bardenheier B, Prevots DR, Khetsuriani N et al. Tetanus surveillance – united states, 1995–1997. MMWR Morb. Mortal. Wkly Rep.47, 1–13 (1998).
- Vandelaer J, Birmingham M, Gasse F, Kurian M, Shaw C, Garnier S. Tetanus in developing countries: an update on the Maternal and Neonatal Tetanus Elimination Initiative. Vaccine21, 3442–3445 (2003).
- Sanders RK. The management of tetanus 1996. Trop. Doct.26, 107–115 (1996).
- Scher KS, Baldera A, Wheeler WE, Walker R, Jones CW. Inadequate tetanus protection among the rural elderly. South Med. J.78, 153–156 (1985).
- LaForce FM, Young LS, Bennett JV. Tetanus in the United States (1965–1966): epidemiologic and clinical features. N. Engl. J. Med.280, 569–574 (1969).
- Fischer MGW, Sunakorn P, Duangman C. Otogenous tetanus: a sequelae of chronic ear infections. Am. J. Dis. Child.131, 445–446 (1977).
- Nourmand A. Clinical studies on tetanus: notes on 42 cures in southern Iran with special emphasis on portal of entry. Clin. Pediatr.12, 652–653 (1973).
- Montecucco C, Schiavo G. Mechanism of action of tetanus and botulinum neurotoxins. Mol. Microbiol.13, 1–8 (1994).
- Weinstein L. Tetanus. N. Engl. J. Med.289, 293–296 (1973).
- Kerr JH, Corbett JL, Prys-Roberts C, Smith AC, Spalding JM. Involvement of the sympathetic nervous system in tetanus: studies on 82 cases. Lancet2, 236–241 (1968).
- Turton K, Chaddock JA, Acharya KR. Botulinum and tetanus neurotoxins: structure, function and therapeutic utility. Trends Biochem Sci.27, 552–558 (2002).
- Collingridge GL, Davies J. The in vitro inhibition of GABA release by tetanus toxin. Neuropharmacology21, 851–855 (1982).
- Farrar JJ, Yen LM, Cook T et al. Tetanus. J. Neurol. Neurosurg. Psychiatry69, 292–301 (2000).
- Goulon M, Girard O, Grosbuis S, Desormeau JP, Capponi MF. Antitetanus antibodies. Assay before anatoxinotherapy in 64 tetanus patients. Nouv. Presse Med.1, 3049–3050 (1972).
- Henderson DK. Infectious disease emergencies: the clostridial syndromes. West. J. Med.129, 101–106 (1978).
- Tseuda K, Oliver PB, Richter RW. Cardio-vascular manifestations of tetanus. Anesthesiology40, 588–592 (1974).
- Rose AG. Catecholamine-induced myocardial damage associated with phaeochromocytomas and tetanus. S. Afr. Med. J.48, 1285–1289 (1974).
- Hollow VM, Clarke GM. Autonomic manifestations of tetanus. Anaesth. Intensive Care3, 142–147 (1975).
- Idema CD, Harris BN, Ogunbanjo GA, Durrheim DN. Neonatal tetanus elimination in Mpumalanga province, South Africa. Trop. Med. Int. Health7, 622–624 (2002).
- Ablett JJL. Analysis and main experience in 82 patients treated in the Leeds Tetanus Unit. Symposium on Tetanus in Great Britain. National Lending Library, Boston spa, UK (1967).
- Yen LM, Dao LM, Day NP et al. Role of quinine in the high mortality of intramuscular injection tetanus. Lancet17(344), 786–787 (1994).
- Apte NM, Karnad DR. Short report: the spatula test: a simple bedside test to diagnose tetanus. Am. J. Trop. Med. Hyg.53, 386–387 (1995).
- Clarke G, Hill RG. Effects of a focal penicillin lesion on responses of rabbit cortical neurones to putative neurotransmitters. Br. J. Pharmacol.44, 435–441 (1972).
- Brook I. Presence of β-lactamase-producing bacteria and β-lactamase activity in abscesses. Am. J. Clin. Pathol.86, 97–101 (1986).
- Ahmadsyah I, Salim A. Treatment of tetanus: an open study to compare the efficacy of procaine penicillin and metronidazole. Br. Med. J. Clin. Res. Ed.291, 648–650 (1985).
- Yen LM, Dao LM, Day NPJ. Management of tetanus: a comparison of penicillin and metronidazole. Presented at: Symposium of Antimicrobial Resistance in Southern Viet Nam. Ho Chi Minh City, Vietnam 1997.
- Abrutyn E, Berlin JA. Intrathecal therapy in tetanus. A meta-analysis. JAMA266, 2262–2267 (1991).
- Kapoor W, Carey P, Karpf M. Induction of lactic acidosis with intravenous diazepam in a patient with tetanus. Arch. Intern. Med.141, 944–945 (1981).
- Powles AB, Ganta R. Use of vecuronium in the management of tetanus. Anaesthesia40, 879–881 (1985).
- Engrand N, Guerot E, Rouamba A, Vilain G. The efficacy of intrathecal baclofen in severe tetanus. Anesthesiology90, 1773–1776 (1999).
- Santos ML, Mota-Miranda A, Alves-Pereira A, Gomes A, Correia J, Marçal N. Intrathecal baclofen for the treatment of tetanus. Clin. Infect. Dis.38, 321–328 (2004).
- Engrand N, Vilain G, Rouamba A, Benhamou, D. Value of intrathecal baclofen in the treatment of severe tetanus in the tropical milieu. Med. Trop.60, 385–388 (2000).
- Buchanan N, Smit L, Cane RD, De Andrade M. Sympathetic over activity in tetanus: fatality associated with propranolol. Br. Med. J.2, 254–255 (1978).
- Rocke DA, Wesley AG, Pather M, Calver AD, Hariparsad D. Morphine in tetanus – the management of sympathetic nervous system overactivity. S. Afr. Med. J.70, 666–668 (1986).
- Thwaites CL, Yen LM, Loan HT et al. Magnesium sulphate for treatment of severe tetanus: a randomised controlled trial. Lancet368, 1436–1443 (2006).
- Attygalle D, Rodrigo N. Magnesium as first line therapy in the management of tetanus: a prospective study of 40 patients. Anaesthesia57, 811 (2002).
- James MF, Manson ED. The use of magnesium sulphate infusions in the management of very severe tetanus. Intensive Care Med.11, 5–12 (1985).
- Ceneviva GD, Thomas NJ, Kees-Folts D. Magnesium sulfate for control of muscle rigidity and spasms and avoidance of mechanical ventilation in pediatric tetanus. Pediatr. Crit. Care Med.4, 480–484 (2003).
- Lipman J, James MF, Erskine J, Plit ML, Eidelman J, Esser JD. Autonomic dysfunction in severe tetanus: magnesium sulfate as an adjunct to deep sedation. Crit. Care Med.15, 987–988 (1987).
- Lishajko F. Releasing effect of calcium and phosphate on catecholamines, ATP, and protein from chromaffin cell granules. Acta Physiol. Scand.79, 575–584 (1970).
- von Euler US, Lishajko F. Effects of Mg2+ and Ca2+ on noradrenaline release and uptake in adrenergic nerve granules in differential media. Acta Physiol. Scand.89, 415–422 (1973).
- Sun KO, Chan YW, Cheung RT, So PC, Yu YL, Li PC. Management of tetanus: a review of 18 cases. J. R. Soc. Med.87, 135–137 (1994).
- Thayaparan B, Nicoll A. Prevention and control of tetanus in childhood. Curr. Opin. Pediatr.10, 4–8 (1998).
- American Academy of Pediatrics. Tetanus (lockjaw). In: 2006 Red Book: Report of the Committee on Infectious Diseases (27th Edition). Pickering LK (Ed.). Elk Grove Village, IL, USA 650 (2006).
- Roper M, Vandelaer J, Gasse F. Maternal and neonatal tetanus. Lancet370, 1947–1959 (2007).
- WHO, UNICEF and UNFPA. Maternal and neonatal tetanus elimination by 2005: strategies for achieving and maintaining elimination. WHO/V&B/02.09, WHO, United Nations Children’s Fund, United Nations Population Fund, Geneva, Switzerland (2000).